| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.0092 | 1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.0076 | 1 |